Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Neurorehabilitation and Neural Repair|February 9, 2013
Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potentialMichael P Kahle, Gregory J BixJournal of Molecular Signaling|April 21, 2016
Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto-inhibitionMichael P Kahle, Bruce D CuevasStroke Research and Treatment|January 18, 2013
Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke TreatmentsMichael P Kahle, Gregory J BixFrontiers in Pharmacology|September 1, 2012
Perlecan and the blood-brain barrier: beneficial proteolysis?Jill Roberts, Michael P Kahle, Gregory J BixBiochimica Et Biophysica Acta|February 5, 2014
MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cellsAhmed A Mirza, Michael P Kahle, Magdalene Ameka, et al.The Biochemical Journal|September 6, 2014
MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cellsMagdalene Ameka, Michael P Kahle, Mathew Perez-Neut, et al.Neuroreport|May 31, 2012
Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissueMichael P Kahle, Boyeon Lee, Tony Pourmohamad, et al.JCO Precision Oncology|November 22, 2024
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer TypesVijaykumar R Holla, Michael P Kahle, Sun-Hee Kim, et al.JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.Journal of Hepatology|November 16, 2023
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinomaTimothy P DiPeri, Ming Zhao, Kurt W Evans, et al.Pageof 2